The Rogel Cancer Center is a distinguished National Cancer Institute comprehensive cancer center. Our commitment to eradicating cancer is driven by pioneering research and collaborations between scientists and clinicians. Our cancer center's focused efforts advance from groundbreaking laboratory investigations to the seamless application of these discoveries in patient care. We offer a variety of programs to support these endeavors. To learn more about each program you can click on the below links and/or click on a program leader's name to send them an email directly.

Cancer Control and Population Sciences

Leads: Christine Veenstra, M.D., C. Leigh Pearce, Ph.D., M.P.H., and Lauren Wallner, Ph.D., M.P.H. 

Translational and Clinical Research

Leads: Co-Leaders: Theodore Lawrence, M.D., Ph.D., Joshi Alumkal, M.D. and Ulka Vaishampayan, MBBS, FAB 

Cancer Hematopoiesis & Immunology

Leads: Co-Leaders: Ryan Wilcox, M.D., Ph.D. and Weiping Zou, M.D., Ph.D.

Cancer Genetics Research

Leads: Co-Leaders: Sami Malek, Ph.D., and Kathy Cho, M.D. 

Signaling and Tumor Microenvironment 

Leads: Co-Leaders: Yatrik Shah, Ph.D., and Marina Pasca Di Magliano, Ph.D. 

Developmental Therapeutics 

Leads: Co-Leaders: Jolanta Grembecka, Ph.D., and Judith Sebolt-Leopold, Ph.D.